Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Vulvar Neoplasms 1 Uterine Cervical Neoplasms 1 Sarcoma, Kaposi 1 Prostate Cancer Recurrent 1 Ovarian Neoplasms 1

Interventions

pembrolizumab 34 Cisplatin 29 Paclitaxel 15 Brachytherapy 15 Radiotherapy 14 Carboplatin 14 Bevacizumab 14 Blood Specimen Collection 13 Specimen Handling 12 Magnetic Resonance Spectroscopy 11 Colposcopy 11 Nivolumab 10 Drug Therapy 10 atezolizumab 8 Human Papillomavirus DNA Tests 8 Gemcitabine 8 lenvatinib 7 Radiation 6 Platinum 6 Biopsy 6 toripalimab 5 cemiplimab 5 Surveys and Questionnaires 5 Standard of Care 5 Radiotherapy, Intensity-Modulated 5 Practice Guidelines as Topic 5 Patient Navigation 5 Fulvestrant 5 Fluorodeoxyglucose F18 5 zimberelimab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Uterine Cervical Neoplasms × Nelfinavir × 1 year × Clear all

NCT03256916 2026-02-24

NELCER

Tata Memorial Hospital

Phase 3 Completed

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡